Patient tumor samples will be tested using a common panel of genes agreed upon by all centers. Test results will rely upon common pipelines for alignment, analysis, and variant calling; common controls will ensure genomic data is high-quality and uniform.
Ultimately, these molecular diagnostic methodologies will be used to define clinical groups to determine appropriate therapies.
Cross-validate panel of molecular markers available within Cancer Core Europe to ensure results are robust, high-quality, and uniform across centers.
Implement common reporting form for joint Cancer Core Europe projects
Share information on molecularly-defined clinical subgroupings within Cancer Core Europe to help inform therapy decision-making
About Cancer Core Europe
Six leading cancer centers have joined forces to form Cancer Core Europe - a European cancer association carrying out innovative research propelling cancer medicine into a new era. Cancer Core Europe’s efforts will pave the way for a multi-site cancer institute, which will drive the development of new treatments and earlier diagnoses for patients and more effective cancer prevention for Europe’s citizens.